Bufalin suppresses ovarian cancer cell proliferation via EGFR pathway

Abstract. Background:. Previous studies have shown that bufalin exerts antitumor effects through various mechanisms. This study aimed to determine the antineoplastic mechanism of bufalin, an extract of traditional Chinese medicine toad venom, in ovarian cancer. Methods:. The 3-(4,5-Dimethyl-2-thiazo...

Full description

Bibliographic Details
Main Authors: Lei Dou, Dan Zou, Feiran Song, Yuxin Jin, Yin Li, Yi Zhang, Yanjie Yin, Xiuyuan Hao
Format: Article
Language:English
Published: Wolters Kluwer 2022-02-01
Series:Chinese Medical Journal
Online Access:http://journals.lww.com/10.1097/CM9.0000000000001879
_version_ 1818501408434946048
author Lei Dou
Dan Zou
Feiran Song
Yuxin Jin
Yin Li
Yi Zhang
Yanjie Yin
Xiuyuan Hao
author_facet Lei Dou
Dan Zou
Feiran Song
Yuxin Jin
Yin Li
Yi Zhang
Yanjie Yin
Xiuyuan Hao
author_sort Lei Dou
collection DOAJ
description Abstract. Background:. Previous studies have shown that bufalin exerts antitumor effects through various mechanisms. This study aimed to determine the antineoplastic mechanism of bufalin, an extract of traditional Chinese medicine toad venom, in ovarian cancer. Methods:. The 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl tetrazolium bromide (MTT), 5-ethynyl-2′-deoxyuridine (EdU), and colony formation assays were used to investigate the antiproliferative effect of bufalin on the ovarian cancer cell line SK-OV-3. Molecular docking was used to investigate the combination of bufalin and epidermal growth factor receptor (EGFR) protein. Western blotting was performed to detect the expression of EGFR protein and its downstream targets. Results:. Bufalin inhibited the proliferation of SK-OV-3 cells in a dose- and time-dependent manner. Bufalin was confirmed to combine with EGFR protein using molecular docking and downregulate expression of EGFR. Bufalin inhibited phosphorylation of EGFR, protein kinase B (AKT), and extracellular signal-regulated kinase (ERK). Conclusion:. Bufalin suppresses the proliferation of ovarian cancer cells through the EGFR/AKT/ERK signaling pathway.
first_indexed 2024-12-10T20:55:46Z
format Article
id doaj.art-4988446036d14108ad6b251be9ef2b6c
institution Directory Open Access Journal
issn 0366-6999
2542-5641
language English
last_indexed 2024-12-10T20:55:46Z
publishDate 2022-02-01
publisher Wolters Kluwer
record_format Article
series Chinese Medical Journal
spelling doaj.art-4988446036d14108ad6b251be9ef2b6c2022-12-22T01:33:58ZengWolters KluwerChinese Medical Journal0366-69992542-56412022-02-01135445646110.1097/CM9.0000000000001879202202200-00012Bufalin suppresses ovarian cancer cell proliferation via EGFR pathwayLei DouDan ZouFeiran SongYuxin JinYin LiYi ZhangYanjie YinXiuyuan HaoAbstract. Background:. Previous studies have shown that bufalin exerts antitumor effects through various mechanisms. This study aimed to determine the antineoplastic mechanism of bufalin, an extract of traditional Chinese medicine toad venom, in ovarian cancer. Methods:. The 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl tetrazolium bromide (MTT), 5-ethynyl-2′-deoxyuridine (EdU), and colony formation assays were used to investigate the antiproliferative effect of bufalin on the ovarian cancer cell line SK-OV-3. Molecular docking was used to investigate the combination of bufalin and epidermal growth factor receptor (EGFR) protein. Western blotting was performed to detect the expression of EGFR protein and its downstream targets. Results:. Bufalin inhibited the proliferation of SK-OV-3 cells in a dose- and time-dependent manner. Bufalin was confirmed to combine with EGFR protein using molecular docking and downregulate expression of EGFR. Bufalin inhibited phosphorylation of EGFR, protein kinase B (AKT), and extracellular signal-regulated kinase (ERK). Conclusion:. Bufalin suppresses the proliferation of ovarian cancer cells through the EGFR/AKT/ERK signaling pathway.http://journals.lww.com/10.1097/CM9.0000000000001879
spellingShingle Lei Dou
Dan Zou
Feiran Song
Yuxin Jin
Yin Li
Yi Zhang
Yanjie Yin
Xiuyuan Hao
Bufalin suppresses ovarian cancer cell proliferation via EGFR pathway
Chinese Medical Journal
title Bufalin suppresses ovarian cancer cell proliferation via EGFR pathway
title_full Bufalin suppresses ovarian cancer cell proliferation via EGFR pathway
title_fullStr Bufalin suppresses ovarian cancer cell proliferation via EGFR pathway
title_full_unstemmed Bufalin suppresses ovarian cancer cell proliferation via EGFR pathway
title_short Bufalin suppresses ovarian cancer cell proliferation via EGFR pathway
title_sort bufalin suppresses ovarian cancer cell proliferation via egfr pathway
url http://journals.lww.com/10.1097/CM9.0000000000001879
work_keys_str_mv AT leidou bufalinsuppressesovariancancercellproliferationviaegfrpathway
AT danzou bufalinsuppressesovariancancercellproliferationviaegfrpathway
AT feiransong bufalinsuppressesovariancancercellproliferationviaegfrpathway
AT yuxinjin bufalinsuppressesovariancancercellproliferationviaegfrpathway
AT yinli bufalinsuppressesovariancancercellproliferationviaegfrpathway
AT yizhang bufalinsuppressesovariancancercellproliferationviaegfrpathway
AT yanjieyin bufalinsuppressesovariancancercellproliferationviaegfrpathway
AT xiuyuanhao bufalinsuppressesovariancancercellproliferationviaegfrpathway